Clinical Trial Update: Evaluation of the Mixture Myoinositol:D-chiro-inositol 3.6:1 in Women With Polycystic Ovary Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating a myo-inositol:D-chiro-inositol 3:6:1 mixture for Polycystic Ovary Syndrome and infertility has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Polycystic Ovary Syndrome

Drugs mentioned

• Myoinositol:D-chiro-inositol 3.6:1 mixture

Snippet

Sponsor: Biosearch S.A. | Conditions: Polycystic Ovarian Syndrome, Infertility | Phase 2, Phase 3 | Status: COMPLETED